EEF2K and multiple sclerosis: A heightened population of Th17 cells has been detected within the central nervous system (CNS) lesions of individuals with multiple sclerosis, a condition in which immune cells target the CNS, leading to demyelination and subsequent paralysis and walking disability.35 To investigate the potential influence of eEF2K on multiple sclerosis (MS), we established an experimental autoimmune encephalomyelitis (EAE) model.